eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2014
vol. 39
 
Share:
Share:
abstract:

Clinical immunology
Hypomethylation of interleukin 6 correlates with renal involvement in systemic lupus erythematosus

Chun Tang
,
Yun Li
,
Xiaojun Lin
,
Jinghua Ye
,
Weinian Li
,
Zhixiang He
,
Fangfei Li
,
Xiaoyan Cai

(Centr Eur J Immunol 2014; 39 (2): 203–208)
Online publish date: 2014/06/27
View full text Get citation
 
PlumX metrics:
Objective: To analyze peripheral blood interleukin 6 (IL-6) methylation status and its clinical significance in patients with systemic lupus erythematosus (SLE).

Material and methods: Blood samples from 41 adult patients with SLE, and 20 healthy controls were collected. The methylation status of IL-6 was determined by methylation specific polymerase chain reaction (MSP). The IL-6 expression was detected by real-time PCR. Correlations between IL-6 methylation status and clinical features or laboratory findings in patients with SLE were investigated.

Results: The methylation status and expression of IL-6 in peripheral blood could reflect the level in peripheral blood mononucleated cells (PBMCs) of SLE. Significantly positive correlation was found between IL-6 hypomethylation and renal disorder. Interleukin 6 hypomethylation was found negatively correlated with serum C3.

Conclusions: The detection of IL-6 methylation status in peripheral blood could reflect the status in PBMC with SLE. Interleukin 6 may play a role in renal disorder with SLE patients. Interleukin 6 could be considered as a new biomarker for predicting SLE flare.
keywords:

systemic lupus erythematosus, hypomethylation, interleukin-6, peripheral blood

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.